Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-09-30 Higgons John Duncan Chief Operating Officer Exercise or conversion +10,000 $0.30 $3K 151,835
2015-09-30 Higgons John Duncan Chief Operating Officer Exercise or conversion · Stock option (right to buy) −10,000 245,022
2015-09-30 Biller Scott Chief Scientific Officer Exercise or conversion +5,500 $31.64 $174K 39,570
2015-09-30 Biller Scott Chief Scientific Officer Sale −5,500 $70.44 $387K 34,070
2015-09-30 Biller Scott Chief Scientific Officer Exercise or conversion · Stock option (right to buy) −5,500 290,880
2015-09-25 Cantley Lewis Clayton Jr. Director Sale −2,426 $82.09 $199K 147,854
2015-09-25 Cantley Lewis Clayton Jr. Director Sale −2,426 $82.07 $199K 147,854
2015-09-24 Goddard Glenn Senior Vice President, Finance Exercise or conversion +10,000 10,000
2015-09-24 Goddard Glenn Senior Vice President, Finance Shares withheld for taxes −4,856 $88.89 $432K 5,144
2015-09-24 Goddard Glenn Senior Vice President, Finance Exercise or conversion +856 $23.10 $20K 6,000
2015-09-24 Goddard Glenn Senior Vice President, Finance Sale −6,000 $85.97 $516K 0
2015-09-24 Goddard Glenn Senior Vice President, Finance Exercise or conversion · Restricted stock units −10,000 0
2015-09-24 Goddard Glenn Senior Vice President, Finance Exercise or conversion · Stock option (right to buy) −856 88,242
2015-09-24 Cantley Lewis Clayton Jr. Director Sale −2,426 $84.43 $205K 150,280
2015-09-24 Cantley Lewis Clayton Jr. Director Sale −2,426 $84.42 $205K 150,280
2015-09-15 Higgons John Duncan Chief Operating Officer Exercise or conversion +2,480 $0.30 $750 144,315
2015-09-15 Higgons John Duncan Chief Operating Officer Exercise or conversion +17,520 $0.30 $5K 161,835
2015-09-15 Higgons John Duncan Chief Operating Officer Sale −20,000 $91.11 $1.8M 141,835
2015-09-15 Higgons John Duncan Chief Operating Officer Exercise or conversion · Stock option (right to buy) −2,480 272,542
2015-09-15 Higgons John Duncan Chief Operating Officer Exercise or conversion · Stock option (right to buy) −17,520 255,022

Page 86 of 93 · 1,853 trades